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Abstract
This nationwide study aimed to provide risk estimates for a panel of infections subsequent to pyogenic liver abscesses (PLA) in Taiwan.
In this study, we selected 12 050 patients diagnosed with PLA as our study cohort and 60 250 non-PLA patients as our comparison
cohort. We individually tracked each subject for a 1-year period beginning with their index date to identify those who were
subsequently diagnosed with any of the following infections: pneumonia, endophthalmitis, septic pulmonary embolism, pulmonary
abscess, pleural empyema, meningitis, abscess of prostate, renal and perinephric abscess, epidural spinal abscess, osteomyelitis, necrotiz-
ing fasciitis, splenic abscess, psoas abscess and infectious endocarditis. We found that during the 1-year follow-up period, the subjects
with PLA had a consistently higher incidence of all types of infections than comparison subjects. In particular, compared with subjects
without PLA, the adjusted hazard ratios (HR) of pulmonary abscess, pleural empyema, renal and perinephric abscess, epidural spinal
abscess and splenic abscess were 26.71, 18.56, 43.21, 51.32 and 126.51, respectively. We further analysed the HR of extra-hepatic
Klebsiella pneumoniae infections among patients with PLA caused by K. pneumoniae. We found that the HR was higher for 12 of the 15
analysed extra-hepatic infections after restricting the analysis to only infections with K. pneumoniae aetiologies.
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Introduction
Pyogenic liver abscess (PLA) is a potentially fatal disease. It
currently accounts for three-quarters of all the liver
abscesses occurring in industrialized countries [1], with one
out of every 4500–7000 hospital admissions being due to a
liver abscess [2,3]. Before the 1980s, the organism most
commonly isolated from liver abscesses was Escherichia coli,
but in Taiwan there has been a shift to Klebsiella pneumoniae,
which is now highly endemic and the major cause of commu-
nity-acquired pyogenic infections [4–7]. Some researchers
are now suggesting that this same aetiological shift is also
occurring in the USA [8], with K. pneumoniae more recently
being found to be the primary causative agent there as well
[9]. In addition to this aetiological shift, other factors affect-
ing the prognosis of PLA include advancements in antibiotics
and surgical techniques, which have greatly reduced mortality
rates over the last two decades [10].
Although the treatment of PLA continues to evolve and is
currently a topic of controversy among medical practitioners
[11], surgical advancements have already reduced mortality
rates to around 11.24% [12]. This can be compared with
rates that were as high as 69% among PLA patients afflicted
between 1928 and 1937 [12], and 24% in a study conducted
on patients in the USA between 1966 and 1978 [13]. On
account of the decreased mortality rates and increased num-
ber of PLA survivors, clinicians need to be more aware of
the sequelae related to having suffered a PLA.
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Patients with PLA often have high rates of bacteraemia
and subsequent metastatic complications, and these rates are
even higher when K. pneumoniae is the causative agent
[4,14]. This is particularly disconcerting because severe com-
plications including septic endogenous endophthalmitis, meta-
static infections of the brain and lung, and necrotizing fasciitis
have been reported in PLA patients all over the world [15–
20]. Therefore, to better characterize the risk of sequelae to
PLA, this study set out to provide risk estimates for a panel
of infections subsequent to PLA using a population-based
dataset in Taiwan.
Methods
Database
The data for this study were sourced from Taiwan’s National
Health Insurance Research Database (NHIRD). The NHIRD
is derived from the Taiwan National Health Insurance (NHI)
programme and is maintained by the National Health
Research Institute, Taipei, Taiwan. The NHIRD includes the
registration files and original claims data for the reimburse-
ment of 22.89 million of the country’s 22.96 million inhabit-
ants as of 2008. Several studies have demonstrated the high
validity of the data from the NHI programme [21–23].
Because the NHIRD consists of anonymous secondary
data that are routinely released to the public for research
purposes, this study was exempt from full review by the Tai-
pei Medical University Institutional Review Board.
Study population
This retrospective cohort study included both a study cohort
and a comparison cohort. In selecting our study cohort, we
first identified 14 343 subjects from the NHIRD who visited
outpatient care centres or were hospitalized with a principal
diagnosis of PLA (International Classification of Diseases, 9th
edition, clinical modification (ICD-9-CM) code 572.0)
between 1 January 2006 and 31 December 2008. We
assigned their first visits for PLA during this study period as
their index dates. We then excluded subjects who had been
diagnosed with PLA before their index date (n = 1154) to
include only new-onset patients and those <18 years old
(n = 148) to restrict our analysis to the adult population.
We also excluded subjects who had received a diagnosis of
any of the infections selected for investigation (including
pneumonia, endophthalmitis, septic pulmonary embolism, pul-
monary abscess, pleural empyema, meningitis, abscess of
prostate, renal and perinephric abscess, epidural spinal
abscess, osteomyelitis, pyogenic arthritis, necrotizing fasciitis,
splenic abscess, psoas abscess and infectious endocarditis)
within the 6 months before their index dates (n = 818). Ulti-
mately, 12 050 subjects with PLA were included in the study
cohort.
We also used the NHIRD to select the comparison
cohort. In total, 60 250 subjects were randomly extracted
from the NHIRD, with a ratio of 1:5, matched with the study
cohort on age, sex, urbanization level (five levels, with one
referring to the most urbanized and five referring to the
least), and the year of index date (2006–2008). All 359 cities/
towns in Taiwan were stratified into five groups ranked by
urbanization level in accordance with a previous study with
one referring to the ‘most urbanized’ and five referring to
the ‘least urbanized’ [24]. We matched the distribution of
urbanization level between the study subjects and the com-
parison subjects to help to assure that these two cohorts
were reasonably similar in terms of unmeasured neighbour-
hood socio-economic characteristics. Their first use of medi-
cal services occurring in the index year was assigned as the
index date. We also ensured that none of the selected com-
parison cohort had a history of PLA since the initiation of
the Taiwan NHI programme and that none of the selected
comparison subjects had been diagnosed with any type of
the above-mentioned infections during the 6 months preced-
ing their index dates.
As a result, we included 72 300 subjects in this study and
individually tracked each subject for a 1-year period beginning
with their index date to identify those who were subse-
quently diagnosed with any of the following infections: pneu-
monia (ICD-9-CM codes 480–486 or 487.0), endophthalmitis
(ICD-9-CM codes 360.0–360.1), septic pulmonary embolism
(ICD-9-CM codes 415.1), pulmonary abscess (ICD-9-CM
codes 513.0), pleural empyema (ICD-9-CM codes 510), men-
ingitis (ICD-9-CM codes 320–322), abscess of prostate (ICD-
9-CM codes 601.2), renal and perinephric abscess (ICD-9-CM
codes 590.2), epidural spinal abscess (ICD-9-CM codes
324.1), osteomyelitis (ICD-9-CM codes 730), pyogenic arthri-
tis (ICD-9-CM codes 711.0), necrotizing fasciitis (ICD-9-CM
codes 728.86), splenic abscess (ICD-9-CM codes 289.59),
psoas abscess (ICD-9-CM codes 567.0) and infectious endo-
carditis (ICD-9-CM codes 421.0–421.1). These secondary
infectious diseases were selected because they have been
reported to be caused by extra-hepatic metastases from pyo-
genic liver abscesses in previous studies [25].
Klebsiella pneumoniae was identified by ICD-9-CM code
482.0 in the case of pneumonia, and ICD-9-CM code 041.3
in addition to a location code for other sources of infection.
Statistical analysis
We used the SAS statistical package for all statistical analy-
ses. Pearson chi-square tests were used to examine the
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distributions of urbanization level, geographic region (north-
ern, central, eastern and southern Taiwan) and monthly
income and selected medical comorbidities (hypertension,
diabetes, heart disease, lung disease, cancer and acute/
chronic kidney disease) of both patients with and patients
without PLA. These comorbidities were only included if they
either occurred in an inpatient setting or appeared in two or
more ambulatory care claims coded 6 months before the
index date. Separate Stratified Cox proportional hazard
regressions (stratified on age, sex, urbanization level and the
year of index date) were conducted to calculate the hazard
of each selected type of infection following a diagnosis of
PLA. In addition, we further analysed the hazard of having
suffered any type of infections and at least two types of
infection between the study cohort and comparison cohort.
A value of p <0.05 was considered statistically significant.
Results
Of the 72 300 sampled subjects, the mean age was 62.0
(±15.1) years and about 61% were male. We found that
K. pneumoniae (ICD-9-CM code 041.3) was the causative
organism in 73.0% of the patients with PLA in this study.
Table 1 shows that patients with PLA were more likely than
patients without PLA to have the following comorbidities
after matching for age and sex: hypertension (p <0.001), dia-
betes (p <0.001), heart disease (p <0.001), cancer (p <0.001)
and acute/chronic kidney disease (p <0.001). There was no
significant difference in the prevalence of lung disease
between patients with and without PLA (p 0.698). In addi-
tion, Table 1 shows that patients with PLA had a greater
tendency to have no monthly income and to reside in the
southern part of Taiwan than patients without PLA.
The incidence of infection during the 1-year follow-up per-
iod for these two cohorts is presented in Table 2. Subjects
with PLA had a consistently higher incidence of all types of
infection than subjects without PLA during the 1-year follow-
up period. Table 2 also presents the crude and adjusted haz-
ard ratio (HR) for different types of infection between sub-
jects with and without PLA. After adjusting for patient
monthly income, geographic location, hypertension, diabetes,
heart disease, lung disease, cancer (p <0.001) and acute/
chronic kidney disease, stratified Cox proportional hazards
regressions (stratified on age, sex, urbanization level and
index year) consistently revealed that when compared with
subjects without PLA, subjects with PLA had higher HRs for
all types of infection during the 1-year follow-up period. The
risks of some of the selected infections were particularly
high. For example, compared with subjects without PLA, the
adjusted HR of pulmonary abscess, pleural empyema, renal
and perinephric abscess, epidural spinal abscess and splenic
abscess were 26.71, 18.56, 43.21, 51.32 and 126.51, respec-
tively. Fig. 1 presents the pneumonia-free survival curves by
the Kaplan–Meier method.
Table 3 further analysed the incidence and HR of extra-
hepatic K. pneumoniae infections among patients with PLA
caused by K. pneumoniae. We only analysed for K. pneumo-
niae because it was the most prevalent infectious agent in
this study.
Discussion
This study reported risk estimates for a panel of infections
subsequent to suffering a PLA, which ranged between 3.06
for osteomyelitis, and 126.51 for splenic abscess. We also
conducted another analysis on the incidence and HR of
TABLE 1. Demographic characteristics and comorbid medi-
cal disorders for patients in Taiwan with pyogenic liver
abscess and patients in the comparison cohort, 2006–2008
(n = 72 300)
Variable
Patients with
pyogenic liver
abscess
(n = 12 050)
Comparison
patients
(n = 60 250)
p value
Total
no.
Column
%
Total
no.
Column
%
Sex
Male 7332 60.8 36 660 60.8 1.000
Female 4718 39.2 23 590 39.2
Age (years)
18–39 1264 10.5 6320 10.5 1.000
40–49 1858 15.4 9290 15.4
50–59 2927 24.3 14 635 24.3
60–69 2560 21.3 12 800 21.3
70–79 2473 20.5 12 365 20.5
>79 968 8.0 4840 8.0
Urbanization level
1 (most urbanized) 3374 28.0 16 870 28.0 1.000
2 3242 26.9 16 210 26.9
3 1942 16.1 9710 16.1
4 1894 15.7 9470 15.7
(least urbanized) 1598 13.3 7990 13.3
Hypertension 6055 50.3 26 314 43.7 <0.001
Diabetes 5322 44.2 12 160 20.2 <0.001
Heart diseasea 2491 20.7 10 870 18.0 <0.001
Lung diseaseb 1044 8.7 5286 8.8 0.698
Acute/chronic
kidney disease
1341 11.1 3393 5.6 <0.001
Cancer 3241 26.9 3310 5.4 <0.001
Monthly income
NT$0–15 840 5492 45.6 21 196 35.2 <0.001
NT$15 841–25 000 4271 35.4 25 875 43.0
‡NT$25 001 2287 19.0 13 179 21.8
Geographic region
Northern 5289 43.9 28 028 46.5 <0.001
Central 2867 23.8 14 493 24.1
Southern 3576 29.7 16 162 26.8
Eastern 318 2.6 1567 2.6
aHeart disease: ischaemic heart disease, arrhythmias and heart failure.
bLung disease: chronic obstructive pulmonary disease, asthma, pulmonary
emphysema and pneumoconiosis.
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extra-hepatic K. pneumoniae infections among patients with
PLA caused by K. pneumoniae to gain better insight into the
possibility that the mechanism underlying the increased risks
detected in this study involved metastasis. We found that
the HR for 12 of the 15 analysed extra-hepatic infections
increased after restricting the analysis to only infections with
K. pneumoniae aetiologies.
The gruop of PLA survivors afflicted with subsequent
infections is likely to grow based on the aetiological shift
among PLA patients. Before the 1980s, the most commonly
isolated organisms from liver abscesses were E. coli, but in
Taiwan there has been a shift to K. pneumoniae as the princi-
pal causative organism, which is now not only endemic but
also the major cause of all community-acquired pyogenic
infections [4–7]. This high prevalence of PLA cases aetiologi-
cally characterized by K. pneumoniae in this study supports
the findings of a previous study conducted on PLA patients
between 1990 and 1996, which found 87.9% of all the PLA
cases in one veteran hospital in Taiwan to be caused by
K. pneumoniae alone, with the remainder being caused by
mixed flora [26].
Hence, it is likely that the increased risks for infection fol-
lowing PLA observed in this study stem from factors accom-
panying the aetiological shift to K. pneumoniae as the primary
causative agent among PLA infections. Two such accompany-
ing factors through which this mechanism may proceed
include the increased risks for bacteraemia and metastatic
complications among K. pneumoniae-caused PLA. In one study
conducted on all patients in the USA with PLA caused by
K. pneumoniae, it was found that 83% had concurrent bacter-
aemia [4]. This can be compared with another US study con-
ducted on records taken from the period between 1994 and
2005, which only reported rates of bacteraemia reaching
52.1% (95% CI = 50.9–53.3) among 8286 PLA patients with
the most common bacterial sources identified as streptococ-
cus (29.5%) and E. coli (18.1%) [14].
In addition to increased rates of bacteraemia, the same
study found that 28% of the patients with PLA arising from
K. pneumoniae also suffered from metastatic complications
[4]. This is supported by a study conducted in Taiwan on
225 PLA cases sourced from between 1995 and 2000, which
found PLA patients infected with K. pneumoniae to be more
TABLE 2. Crude and adjusted haz-
ard ratios for subsequent extra-
hepatic infections among the sam-
ple patients during the 365-day fol-
low-up period starting from the
index date (n = 72 300)
Types of subsequent
extra-hepatic infections
Patients with
PLA
(n = 12 050)
Comparison
patients
(n = 60 250)
Patients with pyogenic liver abscess
versus comparison
No. (%) No. (%)
Crude HR,
95% CI
Adjusted HRb,
95% CI
Pneumonia 1516 (12.6) 2405 (4.0) 3.46 (3.24–3.70)a 3.25 (3.00–3.52)a
Endophthalmitis 110 (0.9) 33 (0.1) 16.81 (11.39–24.82)a 16.53 (10.99–24.85)a
Septic pulmonary embolism 54 (0.5) 23 (0.1) 11.79 (7.23–19.21)a 9.52 (5.63–16.08)a
Pulmonary abscess 91 (0.8) 14 (0.1) 32.7 (18.65–57.49)a 26.71 (14.86–47.99)a
Pleural empyema 154 (1.3) 33 (0.1) 23.62 (16.21–34.42)a 18.56 (12.48–27.62)a
Meningitis 70 (0.6) 23 (0.1) 15.30 (9.55–24.52)a 14.19 (8.64–23.29)a
Abscess of prostate 16 (0.1) 2 (0.1) 40.05 (9.21–174.21)a 18.31 (4.02–83.40)a
Renal and perinephric abscess 59 (0.5) 6 (0.1) 49.40 (21.33–114.44)a 43.21 (18.25–102.27)a
Epidural spinal abscess 12 (0.1) 1 (0.1) 60.05 (7.81–461.86)a 51.32 (6.34–415.64)a
Osteomyelitis 92 (0.8) 117 (0.2) 3.96 (3.01–5.20)a 3.06 (2.27–4.12)a
Pyogenic arthritis 37 (0.3) 32 (0.1) 5.80 (3.61–9.31)a 4.71 (2.83–7.84)a
Necrotizing fasciitis 46 (0.4) 37 (0.1) 6.24 (4.04–9.62)a 3.83 (2.40–6.12)a
Splenic abscess 54 (0.5) 2 (0.1) 135.60 (33.06–556.23)a 126.51 (30.37–527.09)a
Psoas abscess 16 (0.1) 4 (0.1) 20.03a (6.69–59.91) 21.94a (6.96–69.13)
Infectious endocarditis 34 (0.3) 10 (0.1) 17.05 (8.42–34.51)a 16.20 (7.72–34.00)a
95% CI, 95% confidence interval; HR, hazard ratio; PLA, pyogenic liver abscess.
aIndicates p <0.001; hazard ratio was calculated by the stratified Cox regression model (stratified on age, sex, urbani-
zation level, and index date).
bAdjustments are made for patient monthly income, geographic location, hypertension, diabetes, heart disease, lung
disease, cancer and acute/chronic kidney disease.
FIG. 1. Pneumonia-free survival rates for patients with pyogenic
liver abscess and comparison patients in Taiwan.
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likely to have had metastatic complications (adjusted
OR = 5.0; 95% CI = 1.1–47) than cases caused by other bac-
teria after controlling for age, sex and the duration of symp-
toms before admission [25]. The same study also found
cases presenting with bacteraemia, which is more likely
among patients with PLA caused by K. pneumoniae [4,14], to
be at an increased risk for metastatic complications (adjusted
OR = 5.4; 95% CI = 1.4–30) [25], suggesting that patients
with PLA caused by K. pneumoniae are particularly vulnerable
to metastasis.
Therefore, it is possible that the increased risks for extra-
hepatic infection following PLA may at least in part be
explained through a metastatic mechanism. This is supported
by our further analysis on the incidence and HR of extra-
hepatic K. pneumoniae infections among patients with PLA
caused by K. pneumoniae (Table 2). We observed that the
HR was higher for 12 of the 15 analysed extra-hepatic infec-
tions after restricting the analysis to only infections with
K. pneumoniae aetiologies.
This study suffered from two principal limitations. First,
some clinically relevant patient and lifestyle information, such
as smoking status, alcohol consumption and dietary habits,
body mass index, and pharmaceutical use was not available
through the administrative dataset. Another study recently
conducted in Taiwan has suggested that diabetes and alcohol-
ism are significant risk factors for developing extra-hepatic
metastatic infections from PLA [25], so in addition to adjust-
ing for urbanization level, which may reflect lifestyle, we also
adjusted for both obesity and alcohol abuse/dependence syn-
drome. Nevertheless, the association between PLA and sub-
sequent infections detected in this study may be partially
explained by the residual confounding of these unadjusted
factors.
Second, the risk of subsequent infection may vary with
the severity of the PLA infection; however, there were no
laboratory measures that could serve as a proxy for severity
(antibody titres, bacterial concentrations, bacterial identifica-
tion, or other biomarkers) available in the dataset.
This study suggested an increased risk of infection among
individuals with a PLA. Future studies will be needed to
elucidate the mechanisms by which PLA is associated with sub-
sequent infections, and to clarify whether the identity of the
causative organism influences the risk of subsequent infection.
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TABLE 3. Crude and adjusted haz-
ard ratios for extra-hepatic Klebsi-
ella pneumoniae infections among
the sample patients during the
365-day follow-up period starting
from the index date (n = 70 089)
Types of extra-hepatic
Klebsiella pneumoniae
infections
Patients with
K. pneumoniae-
caused
PLA (n = 9839)
Comparison
(n = 60 250)
Patients with
pyogenic
liver abscess
versus Comparison
No. (%) No. (%)
Adjusted HRb,
95% CI
Pneumonia 1021 (10.4) 913 (1.5) 6.96 (6.33–7.64) a
Endophthalmitis 84 (0.9) 33 (0.1) 15.59 (10.20–23.83)a
Septic pulmonary embolism 44 (0.5) 19 (0.1) 11.92 (6.70–21.22)a
Pulmonary abscess 69 (0.7) 8 (0.1) 42.81 (20.07–91.32)a
Pleural empyema 121 (1.2) 24 (0.1) 24.94 (15.73–39.54)a
Meningitis 51 (0.5) 15 (0.1) 18.83 (10.28–34.47)a
Abscess of prostate 11 (0.1) 1 (0.1) 32.91 (4.09–264.69)b
Renal and perinephric abscess 45 (0.5) 5 (0.1) 51.45 (19.95–132.69)a
Epidural spinal abscess 8 (0.1) – –
Osteomyelitis 63 (0.6) 94 (0.2) 3.41 (2.42–4.82)a
Pyogenic arthritis 28 (0.3) 24 (0.1) 5.67 (3.15–10.20)a
Necrotizing fasciitis 34 (0.4) 24 (0.1) 5.41 (3.08–9.50)a
Splenic abscess 42 (0.4) 2 (0.1) 113.15 (26.80–477.81)a
Psoas abscess 12 (0.1) 3 (0.1) 24.98a (6.62–94.24)
Infectious endocarditis 24 (0.2) 3 (0.1) 47.53 (13.88–162.71)a
95% CI, 95% confidence interval; HR, hazard ratio; PLA, pyogenic liver abscess.
ap <0.001, bp <0.01. Hazard ratio was calculated by the stratified Cox regression model (stratified on age, sex, urban-
ization level and index date).
bAdjustments are made for patient monthly income, geographic location, hypertension, diabetes, heart disease, lung
disease, cancer and acute/chronic kidney disease.
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